Pfizer CEO: Trial Shows Booster Restores Full Protection

The Hill reports:

Pfizer and BioNTech announced on Thursday that a booster shot of their coronavirus vaccine restores full protection against COVID-19. The companies said that a late-stage clinical trial found that the booster was 95.6 percent effective against symptomatic COVID-19.

The efficacy results are the first from any randomized, controlled trial of a COVID-19 booster, they said. “These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease,” Pfizer CEO Albert Bourla said in a statement.

The trial followed 10,000 individuals aged 16 and older who were given either a booster dose or placebo on average 11 months after completing the initial two doses of the vaccine.

Read the full article.

Pfizer says testing shows booster restores full protection against COVID-19 https://t.co/7qjhQEbql6 pic.twitter.com/Qh4Pph9lfY

— The Hill (@thehill) October 21, 2021